Researchers Discover New Mechanism to Prevent Protein Aggregation in Tissues

Protein aggregation in tissues is a hallmark of various diseases, including neurodegenerative conditions, and is a common occurrence during aging. However, the mechanisms that prevent toxic protein buildup in different tissues remain poorly understood.

A team from the Babraham Institute and the German Center for Neurodegenerative Diseases has identified a backup mechanism for protein quality control that prevents the harmful effects of protein aggregation in specific tissues when the usual molecular monitoring methods fail. Their research focuses on C. elegans and aims to uncover how various tissues handle protein accumulation, potentially providing insights into protecting vulnerable tissues from protein buildup, whether disease-related or age-related.

In aging organisms, proteins can accumulate due to disruptions in protein folding and a decline in protein quality control mechanisms. This protein aggregation can lead to issues in the normal functioning of the organism. The researchers discovered that certain tissues are more susceptible to protein aggregation than others, and the factors behind tissue-specific vulnerability or resistance to protein aggregation have been unclear.

In their experiments with C. elegans, the team found that a tissue-specific mechanism, dubbed 'SAPA' (safeguard against protein aggregation), becomes active when conventional protein quality control mechanisms are compromised. This mechanism, uniquely tailored to the pharyngeal muscles in the worms, prevents protein aggregation even when other control systems fail. When SAPA is activated, it mitigates proteotoxicity and partially restores the function of the affected organ.

To achieve this tissue specificity, SAPA relies on a distinct pathway involving macroautophagy-independent lysosomal degradation, a part of the cell's waste disposal system. Surprisingly, it also employs factors typically associated with the host's response to natural pathogens affecting the digestive tract.

Further investigations revealed that SAPA prevents protein accumulation by recognizing and eliminating newly synthesized proteins before they can form large aggregates. This finding sheds light on why certain areas of the brain may resist protein aggregation, potentially aiding in the development of therapies for protein aggregation-related diseases and strategies to prevent undesirable protein buildup associated with aging.

Dr. Della David, senior author of the study published in PLOS Biology, emphasized the significance of this discovery, stating that it unveils an additional layer of protection for tissues during times of stress, actively halting protein aggregation and restoring organ function. This research provides valuable insights into the complex mechanisms governing protein quality control in different tissues and may pave the way for novel therapeutic interventions in diseases linked to protein aggregation.